Stay updated on Double-Dose Levonorgestrel PK With Efavirenz/Rifampicin Clinical Trial
Sign up to get notified when there's something new on the Double-Dose Levonorgestrel PK With Efavirenz/Rifampicin Clinical Trial page.

Latest updates to the Double-Dose Levonorgestrel PK With Efavirenz/Rifampicin Clinical Trial page
- CheckyesterdayChange DetectedThe footer now displays Revision: v3.6.3 instead of Revision: v3.6.2, indicating a site version update without altering the study details.SummaryDifference0.0%

- Check8 days agoChange DetectedThe page now displays a new site revision label, v3.6.2, replacing the previous v3.6.0, indicating a newer version of the interface without changing the study details.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page now communicates that recruitment is closed and adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study), while the Intervention/Treatment heading formatting was adjusted and the revision label updated to v3.6.0.SummaryDifference0.3%

- Check29 days agoChange DetectedThe page revision was updated from v3.5.4 to v3.5.5, indicating a small platform update rather than changes to study information or layout.SummaryDifference0.0%

- Check51 days agoChange DetectedThe site revision has been updated from v3.5.3 to v3.5.4, signaling a new software release. It likely includes internal fixes or minor UI improvements without altering the displayed study details.SummaryDifference0.0%

- Check72 days agoChange DetectedClinicalTrials.gov’s page footer was updated from revision v3.5.2 to v3.5.3, reflecting a site release rather than any change to the trial record.SummaryDifference0.0%

Stay in the know with updates to Double-Dose Levonorgestrel PK With Efavirenz/Rifampicin Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Double-Dose Levonorgestrel PK With Efavirenz/Rifampicin Clinical Trial page.